Health Care

Issue | Health Care

Health Insurance Tips

Resource | Health Care

SO YOU NEED HEALTH INSURANCE. NOW WHAT?

Having the facts can make all the difference when it comes to health insurance. To make the most of new choices, protections and financial help, you need good information. This guide can help you find quality coverage that won’t break the bank.

Issue | Health Care

Health Insurance Tips

Report | U.S. PIRG Education Fund | Health Care

Should I Stay or Should I Go?

Tips for consumers deciding whether to keep their individual health insurance plan or switch to a new plan.

News Release | U.S. PIRG | Health Care

Tips for Bypassing Healthcare.gov Glitches and Getting Enrolled

While experts work to fix the problems with the federal health insurance marketplace website, U.S. PIRG urges consumers to take advantage of other ways to enroll.

News Release | U.S. PIRG Education Fund | Health Care

U.S. PIRG Education Fund Announces “Health Insurance 101” Campus Education Campaign

U.S. PIRG Education Fund celebrated the kick-off of its new health care outreach and education effort focusing on young Americans. The outreach effort comes as the Affordable Care Act’s “health insurance marketplaces” prepare to open in states across the country.

News Release | U.S. PIRG | Health Care

U.S. PIRG Testifies on “Pay for Delay” Before Senate Subcommittee

Today, Mike Russo, U.S. PIRG's Federal Program Director, testified at a hearing on “Pay-for-Delay Deals: Limiting Competition and Costing Consumers” held by the Senate Judiciary Committee, Subcommittee on Antitrust, Competition and Consumer Rights.

News Release | U.S. PIRG | Health Care

Twenty Top Generic Drugs Delayed By Industry Payoffs

Americans with cancer, heart disease, epilepsy and other conditions have been forced to pay an average of 10 times more than necessary for at least 20 blockbuster drugs, according to a report released today by Community Catalyst and U.S. PIRG.

Report | U.S. PIRG | Health Care

Top Twenty Pay-For-Delay Drugs

Our research revealed 20 major drugs that were subject to an industry practice called “pay for delay,” in which brand name pharmaceutical companies pay off generic drug manufacturers to keep lower cost equivalents off the market, forcing consumers to pay higher brand-name drug prices.

Pages

Subscribe to RSS - Health Care

Priority Action

The overuse of antibiotics on factory farms is threatening these lifesaving antibiotics. Call on the Obama administration to put an end to the worst practices. 

Support Us

Your donation supports U.S. PIRG’s work to stand up for consumers on the issues that matter, especially when powerful interests are blocking progress.

Consumer Alerts

Join our network and stay up to date on our campaigns, get important consumer updates and take action on critical issues.
Optional Member Code